Defining epitope coverage requirements for T cell-based HIV vaccines: Theoretical considerations and practical applications
<p>Abstract</p> <p>Background</p> <p>HIV vaccine development must address the genetic diversity and plasticity of the virus that permits the presentation of diverse genetic forms to the immune system and subsequent escape from immune pressure. Assessment of potential HI...
Main Authors: | Currier Jeffrey R, Robb Merlin L, Michael Nelson L, Marovich Mary A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/9/1/212 |
Similar Items
-
Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/E.
by: Silvia Ratto-Kim, et al.
Published: (2015-01-01) -
The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes.
by: Hongjun Bai, et al.
Published: (2019-06-01) -
Predicting population coverage of T-cell epitope-based diagnostics and vaccines
by: Newman Mark J, et al.
Published: (2006-03-01) -
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells.
by: Michael A Eller, et al.
Published: (2011-01-01) -
Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage.
by: Paul W Fenimore, et al.
Published: (2012-01-01)